ReviewFrontiers in neuroscience2026
Advances in the mechanisms of electroacupuncture in the treatment of cerebral ischemia-reperfusion injury.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral ischemia-reperfusion injury (CIRI) is a critical pathological process that adversely affects neurological recovery and prognosis after reperfusion therapies for ischemic stroke, and effective targeted interventions remain limited. Accumulating experimental and clinical evidence indicates that electroacupuncture (EA), as a traditional Chinese medicine-based intervention with controllable stimulation parameters, can attenuate CIRI and improve neurological outcomes to a certain extent. Current studies suggest that the neuroprotective effects of EA involve integrated modulation of multiple pathological processes, including neuronal apoptosis, inflammatory responses, oxidative stress, blood-brain barrier disruption, angiogenesis, and synaptic plasticity, exhibiting characteristics of multi-target, multi-pathway, and dynamic regulation. Meanwhile, EA stimulation parameters, acupoint selection, and intervention timing play important roles in determining therapeutic efficacy. Based on an overview of the major pathological mechanisms of CIRI, this review systematically summarizes the key molecular pathways and parameter-related features underlying EA intervention, aiming to provide references for mechanistic integration and clinical application of EA in CIRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.